June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Ocular changes in a rat model of Alzheimer’s Disease
Author Affiliations & Notes
  • YuChun Tsai
    Cedars-Sinai Medical Center, Los Angeles, CA
  • Bin Lu
    Cedars-Sinai Medical Center, Los Angeles, CA
  • Sergey Girman
    Cedars-Sinai Medical Center, Los Angeles, CA
  • Clive Svendsen
    Cedars-Sinai Medical Center, Los Angeles, CA
  • Robert Cohen
    Memory Disorders Center, Cedars-Sinai Medical Center, Los Angeles, CA
  • Shaomei Wang
    Cedars-Sinai Medical Center, Los Angeles, CA
  • Footnotes
    Commercial Relationships YuChun Tsai, None; Bin Lu, None; Sergey Girman, None; Clive Svendsen, None; Robert Cohen, None; Shaomei Wang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6361. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      YuChun Tsai, Bin Lu, Sergey Girman, Clive Svendsen, Robert Cohen, Shaomei Wang; Ocular changes in a rat model of Alzheimer’s Disease. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6361.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Alzheimer’s disease (AD) is the most common age-related neurodegenerative disorder which is characterized by a progressive decline in learning, memory and executive functions. In addition to cognitive and behavioral deficits, vision disturbances are prevalent in AD patients. Early diagnosis o f AD remains a considerable challenge. Visual symptoms have been reported in early stage of AD, well before the diagnosis is clearly established. Recent studies have highlighted some retinal changes in AD animals, mainly focused on retinal ganglion cell layer. To further investigate the pathologies of ocular abnormalities, a novel AD transgenic rat model was analyzed.

Methods: The double transgenic rats were homozygous for mutant APPswe and PS1ΔE9 and were on the inbred Fischer-344 background. Eyes from 14-19 months old transgenic and age-matched control rats were prepared for retinal whole mount and cryostat sections.

Results: The amyloid-β (Aβ) plaques were robustly distributed in hippocampus and cortex but hardly detected in the retina. Compared with age-matched wild type controls, the thickness of choroid was reduced; the retinal pigment epithelial (RPE) cells showed hypertrophy and proliferation; activation of Muller glia cells that increased expression of GFAP was more evidence; clear recruitment of macrophages/microglia to choroid; and upregulation of complement system. Furthermore, there was no significant difference in retinal ganglion cell anterograde transportation and pattern of retinal vessels. Of note, the uneven of photoreceptor loss was found in both wild type and mutant rats.

Conclusions: This study demonstrated that there are abnormal ocular changes in the Alzheimer’s rat model. The changes in the ocular tissue can be visualized in real time with modern imaging technologies, therefore eye can be used as a window to facilitate early diagnosis of AD and monitor therapeutic efficacy.

Keywords: 413 aging • 452 choroid  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.